
Recursion is at the forefront of reimagining drug discovery. We are building an AI-native platform spanning biology, chemistry, and clinical development; we've signed validating collaborations with partners across biopharma and tech; and we've built a robust internal pipeline with multiple clinical trials underway.
You will lead business development and licensing activities pertaining to our portfolio of first-in-class and best-in-class molecules. You will work closely with our internal asset leadership teams to identify licensing and co-development opportunities, conduct rigorous technical and commercial due diligence, structure and negotiate high-impact transactions that drive value and validate our underlying platform technology. You'll interact daily with colleagues across Biology, Chemistry, Clinical Development, Safety, CMC, Data Science, Legal, and Finance to drive alignment and deliver with speed.
You will be an essential member of Recursion's Corporate Development team, reporting to our Chief Business Officer. The team is an empowered, execution-minded group of business development and alliance management professionals responsible for building Recursion's clinical- and preclinical-stage portfolio through strategic acquisitions, licensing deals, and partnerships. You will work seamlessly with our asset leadership team that focuses on market intelligence, screening, and technical assessment of potential targets. In this collaborative environment, you will need self-initiative, a collaborative mindset, and the ability to communicate with colleagues at all levels.
This is an office-based role in our New York City office, with flexibility to work remotely as needed. Travel to conferences and partnering events is expected every 4-6 weeks.
At Recursion, we believe that every employee should be compensated fairly. Based on the skills, experience, and qualifications needed for this role, the estimated annual base salary range is: $336,380–$404,140. In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.
#LI-DB1
Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning and AI algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area.
Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.